Cloverleaf Bio

New Haven, CT · Founded 2023 · Privately Held (backing)

Developer of a Ribonucleic Acid (RNA) therapeutics development platform designed to revolutionize cancer therapy and patient outcomes in oncology. Cloverleaf Bio is based in New Haven, CT and was founded in 2023. It has raised $1.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$1.1M
Last round
—
Valuation — not yet established

No valuation for Cloverleaf Bio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($1.1M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Cloverleaf Bio with a free Private Market View account
  • ·Watch Cloverleaf Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cloverleaf Bio funding history

No rounds on record

No funding rounds for Cloverleaf Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Cloverleaf Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cloverleaf Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Cloverleaf Bio

How much has Cloverleaf Bio raised?
Cloverleaf Bio has raised $1.1M in total funding across its recorded rounds.